Search the Newsreel

Haleon slides Wednesday, underperforms market

Haleon PLC (HLN) shares dropped 1.51% to £3.60 on Wednesday, underperforming the broader market as the FTSE 100 Index (UKX) also fell by 0.10%. The company's stock closed significantly below its 52-week high of £4.16, which was reached in February.

Haleon plc (HLN) files Form 6-K on cash tender offer for 2027 3.375% notes

Haleon plc has filed a Form 6-K announcing a cash tender offer for its outstanding 2027 3.375% Fixed Rate Notes, as detailed in an exhibit dated August 11, 2026. This filing serves to inform U.S. investors about the debt-related transaction. The offer targets debt …

Haleon unit launches tender offer for $2 billion 2027 notes

Haleon US Capital LLC, a wholly owned subsidiary of Haleon plc, has launched a tender offer to purchase all outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027. This tender offer is part of Haleon's strategy to manage and optimize its debt portfolio, …

Haleon offers to buy back $2B of 3.375% notes due 2027 to optimize debt portfolio.

Haleon plc's subsidiary, Haleon US Capital LLC, has launched a tender offer to repurchase up to $1.999 billion of its 3.375% senior notes due in March 2027. This strategic move aims to optimize the company's debt portfolio and enhance financial flexibility, contingent on the …

Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed Rate Notes

LONDON, Aug. 11, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces that its wholly owned subsidiary, Haleon US Capital LLC (the "Offeror") is offering to buy back any and all of its outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes …

REG - Haleon PLC Haleon US Capital - Cash tender offer - outstanding 2027 3.375% Notes

Haleon plc announced that its subsidiary, Haleon US Capital LLC, is initiating a cash tender offer to buy back all of its outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027. This move aligns with Haleon's capital allocation strategy and aims to optimize …

Haleon and Singapore's Agency for Science, Technology and Research (A*STAR) Launch New Clinical Study on Women's Metabolic Health in Asia

A new clinical study on the multivitamin and mineral supplement Centrum is designed to generate evidence on metabolic health in midlife Asian women - a group often underrepresented in global nutrition research. The study will contribute to a better understanding of preventive healthcare and …

(HLN) Risk Channels and Responsive Allocation

This article analyzes Haleon Plc (NYSE: HLN), identifying a strong near-term sentiment that could influence a neutral mid and long-term outlook. It highlights a significant 25.0:1 risk-reward setup, targeting a 7.7% gain against a 0.3% risk. The analysis also provides institutional trading strategies, including …

Haleon plc (LON:HLN) Receives Average Recommendation of "Hold" from Analysts

Haleon plc (LON:HLN) has received an average "Hold" recommendation from six analysts, with three suggesting a "buy", two a "sell", and one a "hold". The average 12-month price target for the stock is GBX 395.67, with individual targets ranging from GBX 315 to GBX …

Haleon plc (HLN) Investor Outlook: Exploring a 19.58% Potential Upside in the Healthcare Giant

Haleon plc (HLN), a leader in consumer healthcare with a $44.17 billion market cap, is poised for a potential upside of 19.58%. The company demonstrates stable financial health with modest revenue growth, efficient management, and a balanced dividend yield. Favorable analyst ratings, positive technical …

Haleon PLC Sponsored ADR (NYSE:HLN) Given Average Rating of "Moderate Buy" by Brokerages

Haleon PLC Sponsored ADR (NYSE:HLN) has received a consensus "Moderate Buy" rating from ten brokerages. While some firms upgraded the stock, others downgraded or maintained neutral views. The company recently declared a quarterly dividend of $0.0642 per share, and institutional investors have significantly modified …

Haleon plc (LON:HLN) Passed Our Checks, And It's About To Pay A UK£0.024 Dividend

Haleon plc (HLN) Stock Price, News, Quote & History

This page provides a comprehensive overview of Haleon plc (HLN) stock, including its current price, dividend information, key financial metrics, and performance data. It details the company's business in consumer healthcare, offering products like oral care, vitamins, and pain relief, and compares its performance …

Haleon rises Thursday, outperforms market

Haleon PLC (HLN) shares rose by 1.34% to £3.71 on Thursday, outperforming the broader market as the FTSE 100 Index (UKX) fell by 0.19%. The company's stock closed 10.93% below its 52-week high of £4.16, which was reached on February 18th. This increase occurred …

Haleon plc Stock 12‑Month Price Target Raised to $11.29, Implies 15% Upside

Haleon plc's average 12-month price target has been increased from $11.23 to $11.29 by 15 analysts, with individual forecasts ranging from $8.46 to $13.82. This updated target suggests a potential upside of approximately 15% from the Aug. 4 closing price. The consensus rating from …

Royal Bank of Canada Has $30.67 Million Stock Holdings in Haleon PLC Sponsored ADR $HLN

Royal Bank of Canada increased its holdings in Haleon PLC Sponsored ADR (HLN) by 8.5% in the first quarter, now owning 3.06 million shares valued at approximately $30.67 million. Institutional investors hold 6.67% of HLN, and the stock opened at $9.80 with a market …

ACCO vs. HLN: Which Stock Is the Better Value Option?

Investors with an interest in Consumer Products - Discretionary stocks have likely encountered both Acco Brands (ACCO) and Haleon PLC Sponsored ADR (HLN). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. …

Haleon PLC Revenue Breakdown – SWB:H6D0

This article provides a revenue breakdown for Haleon PLC (SWB:H6D0). Last year, the company generated €12.65 billion in revenue, with its Oral Health segment contributing the most at €3.97 billion. Geographically, EMEA and Latin America were the largest contributors, accounting for €5.27 billion.

FOUNDATION CONSUMER HEALTHCARE ANNOUNCES SENIOR LEADERSHIP CHANGES FOLLOWING STRATEGIC REPOSITIONING INTO WOMEN'S HEALTH

Following successful portfolio streamlining, Foundation Consumer Healthcare sharpens category focus on the high-growth women's health market with two senior leadership appointments. Rupa Bahri, former Haleon executive, has been appointed CEO. Founder and current CEO Greg Bradley will assume the role of chairman of the …

Haleon Canada Appoints Daniela Cavinatto as General Manager

Haleon, a global consumer healthcare company, has appointed Daniela Cavinatto as General Manager for its Canadian operations. Cavinatto brings over 25 years of international leadership experience and a strong track record of driving business growth and leading transformations. In her new role, she will …

Haleon (NYSE: HLN) details share count and voting rights update

Haleon plc has provided an update on its share capital and voting structure as of July 31, 2026. The company reported a total of 8,820,906,422 ordinary shares issued, with 11,879,800 of these held as treasury shares. Consequently, 8,809,026,622 ordinary shares carry voting rights, a …

Sei Investments Co. Grows Stock Position in Haleon PLC Sponsored ADR $HLN

Sei Investments Co. significantly increased its stake in Haleon PLC Sponsored ADR (NYSE:HLN) by 89.4% in the first quarter, now owning 1.29 million shares valued at $12.87 million. Other institutional investors also adjusted their holdings, contributing to hedge funds and institutional investors owning 6.67% …

Haleon PLC (HLN) (H1 2026) Earnings Call Highlights: Organic Growth Improves, North America ...

Haleon (NYSE: HLN) reported accelerated second-quarter organic sales growth of 3.1%, driven by strong performance in North America and emerging markets, and healthy sales in pain relief and oral health. The company maintained its full-year growth outlook of 3% to 5% and anticipates a …

Haleon plc 2026 Q2 - Results - Earnings Call Presentation (NYSE:HLN) 2026-07-30

Haleon plc has published its slide deck in conjunction with its Q2 2026 earnings call. This presentation provides details relevant to the company's financial performance for the quarter ending July 30, 2026. The information is made available to investors following the earnings call.

Haleon falls Friday, underperforms market

Haleon PLC (HLN) shares fell 1.44% to £3.63 on Friday, underperforming the broader market as the FTSE 100 Index also saw a decline. The company's stock closed 12.69% below its 52-week high of £4.16. This performance occurred on an overall dismal trading session for …

HALEON PLC To Go Ex-Dividend On August 13th, 2026 With 0.03226 USD Dividend Per Share

Haleon PLC (NYSE:HLN) is scheduled to go ex-dividend on August 13th, 2026, with a dividend payment of 0.03226 USD per share. This information is relevant for investors looking to receive the upcoming dividend.

Key facts: Haleon PLC ADR (HLN) H1 profit +8.2%; Iran war raises costs

Haleon PLC ADR (HLN) reported an 8.2% increase in H1 adjusted operating profit to £1.36bn, with adjusted EPS up 12% to 10.3p and an interim dividend of 2.4p. The company also completed a £457m buyback. Despite these gains, the Iran war is expected to …

Haleon (NYSE:HLN) Posts Quarterly Earnings Results, Misses Expectations By $0.13 EPS

Haleon (NYSE: HLN) updates F-3 and S-8 links in Form 6-K/A

Haleon plc (NYSE: HLN) filed an amended Form 6-K/A to update the reference to its latest shelf registration statement on Form F-3, filed on July 29, 2026. This amendment clarifies that the company's July 30, 2026, half-year results are incorporated by reference into both …

(HLN) Movement as an Input in Quant Signal Sets

This article analyzes Haleon Plc American Depositary Shares (HLN), highlighting a strong near-term sentiment that could influence neutral mid and long-term outlooks. It details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also provides …

Haleon (NYSE: HLN) lifts H1 2026 dividend and posts half-year results

Haleon plc announced its H1 2026 interim dividend for the year ending December 31, 2026, setting it at 2.4 pence per ordinary share. This signifies a 9% increase from the 2025 interim dividend and is consistent with the company's policy of paying approximately one-third …

[6-K] Haleon plc Current Report (Foreign Issuer)

Haleon plc reported strong financial results for the first half of 2026, with revenue reaching £5,602m, an increase of 2.2% on a reported basis and 2.6% organically. The company saw adjusted diluted EPS rise by 12.0% to 10.3p and adjusted operating profit increase by …

Earnings call transcript: Haleon posts stronger H1 2026 growth, shares dip

Haleon reported stronger first-half sales growth in Q2 2026, driven by improved performance in oral care, pain relief, and emerging markets, and maintained its full-year outlook. Despite the positive operational update, shares dipped by 0.78% in premarket trading. The company highlighted efficiency gains and …